Endocytosis and cancer: An 'Insider' network with dangerous liaisons

Traffic

Volumn 9, Issue 12, 2008, Pages 2011-2021

  Lanzetti, Letizia ^a   Di Fiore, Pier Paolo ^b,c,d  

^a UNIVERSITY OF TURIN   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Cancer; Cell cycle; Endocytosis; Metastases; Mitosis; Recycling; Signaling

Indexed keywords

CAVEOLIN; CAVEOLIN 1; CELL PROTEIN; DYNAMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; HUNTINGTIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN MDM2; PROTEIN NUMB; PROTEIN P53; RAB PROTEIN; RAB11 PROTEIN; RAC PROTEIN; RAS PROTEIN; SYNTAXIN; TUBULIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

APOPTOSIS; AUTOPHAGY; CARCINOGENESIS; CELL CYCLE REGULATION; CELL FATE; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL SELECTION; ENDOCYTOSIS; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; CELL MOVEMENT; ENDOCYTOSIS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 56149094041     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2008.00816.x     Document Type: Review

References (82)

1. Mills IG. The interplay between clathrin-coated vesicles and cell signalling. Semin Cell Dev Biol 2007; 18: 459-470.
2. Mayor S, Pagano RE. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 2007; 8: 603-612.
3. Vieira AV, Lamaze C, Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996; 274: 2086-2089.
4. Kholodenko BN. MAP kinase cascade signaling and endocytic trafficking: A marriage of convenience? Trends Cell Biol 2002; 12: 173-177.
5. Kholodenko BN. Four-dimensional organization of protein kinase signaling cascades: The roles of diffusion, endocytosis and molecular motors. J Exp Biol 2003; 206: 2073-2082.
6. Kholodenko BN. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 2006; 7: 165-176.
7. von Zastrow M, Sorkin A. Signaling on the endocytic pathway. Curr Opin Cell Biol 2007; 19: 436-445.
8. Miaczynska M, Pelkmans L, Zerial M. Not just a sink: Endosomes in control of signal transduction. Curr Opin Cell Biol 2004; 16: 400-406.
9. Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007; 8: 185-194.
10. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 2003; 5: 410-421.
11. Sigismund S, Argenzio E, Tosoni D, Cavallato E, Polo S, Di Fiore PP. Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell 2008; 15: 209-219.
12. Nichols JT, Miyamoto A, Weinmaster G. Notch signaling-constantly on the move. Traffic 2007; 8: 959-969.
13. Coumailleau F, Gonzalez-Gaitan M. From endocytosis to tumors through asymmetric cell division of stem cells. Curr Opin Cell Biol 2008; 20: 462-469.
14. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
15. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
16. Vidal M, Cagan RL. Drosophila models for cancer research. Curr Opin Genet Dev 2006; 16: 10-16.
17. Brumby AM, Richardson HE. Using Drosophila melanogaster to map human cancer pathways. Nat Rev Cancer 2005; 5: 626-639.
18. Giebel B, Wodarz A. Tumor suppressors: Control of signaling by endocytosis. Curr Biol 2006; 16: R91-R92.
19. Crosetto N, Tikkanen R, Dikic I. Oncogenic breakdowns in endocytic adaptor proteins. FEBS Lett 2005; 579: 3231-3238.
20. Lu H, Bilder D. Endocytic control of epithelial polarity and proliferation in Drosophila. Nat Cell Biol 2005; 7: 1232-1239.
21. Jekely G, Sung HH, Luque CM, Rorth P. Regulators of endocytosis maintain localized receptor tyrosine kinase signaling in guided migration. Dev Cell 2005; 9: 197-207.
22. McDonald JA, Pinheiro EM, Kadlec L, Schupbach T, Montell DJ. Multiple EGFR ligands participate in guiding migrating border cells. Dev Biol 2006; 296: 94-103.
23. McDonald JA, Pinheiro EM, Montell DJ. PVF1, a PDGF/VEGF homolog, is sufficient to guide border cells and interacts genetically with Taiman. Development 2003; 130: 3469-3478.
24. Montell DJ. Border-cell migration: The race is on. Nat Rev Mol Cell Biol 2003; 4: 13-24.
25. Wang X, Bo J, Bridges T, Dugan KD, Pan TC, Chodosh LA, Montell DJ. Analysis of cell migration using whole-genome expression profiling of migratory cells in the Drosophila ovary. Dev Cell 2006; 10: 483-495.
26. Balasubramanian N, Scott DW, Castle JD, Casanova JE, Schwartz MA. Arf6 and microtubules in adhesion-dependent trafficking of lipid rafts. Nat Cell Biol 2007; 9: 1381-1391.
27. Caswell P, Norman J. Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol 2008; 18: 257-263.
28. Caswell PT, Norman JC. Integrin trafficking and the control of cell migration. Traffic 2006; 7: 14-21.
29. Jones MC, Caswell PT, Norman JC. Endocytic recycling pathways: Emerging regulators of cell migration. Curr Opin Cell Biol 2006; 18: 549-557.
30. Radhakrishna H, Al-Awar O, Khachikian Z, Donaldson JG. ARF6 requirement for Rac ruffling suggests a role for membrane trafficking in cortical actin rearrangements. J Cell Sci 1999; 112: 855-866.
31. Riley KN, Maldonado AE, Tellier P, D'Souza-Schorey C, Herman IM. Betacap73-ARF6 interactions modulate cell shape and motility after injury in vitro. Mol Biol Cell 2003; 14: 4155-4161.
32. Schlunck G, Damke H, Kiosses WB, Rusk N, Symons MH, Waterman-Storer CM, Schmid SL, Schwartz MA. Modulation of Rac localization and function by dynamin. Mol Biol Cell 2004; 15: 256-267.
33. Palamidessi A, Frittoli E, Garre M, Faretta M, Mione M, Testa I, Diaspro A, Lanzetti L, Scita G, Di Fiore PP. Endocytic trafficking of Rac is required for its activation and for the spatial restriction of signaling in cell migration. Cell 2008; 134: 135-147.
34. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, Schwartz MA. Integrins regulate Rac targeting by internalization of membrane domains. Science 2004; 303: 839-842.
35. del Pozo MA, Balasubramanian N, Alderson NB, Kiosses WB, Grande-Garcia A, Anderson RG, Schwartz MA. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat Cell Biol 2005; 7: 901-908.
36. Grande-Garcia A, Echarri A, de Rooij J, Alderson NB, Waterman-Storer CM, Valdivielso JM, del Pozo MA. Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J Cell Biol 2007; 177: 683-694.
37. Pelkmans L, Fava E, Grabner H, Hannus M, Habermann B, Krausz E, Zerial M. Genome-wide analysis of human kinases in clathrin- and caveolae/ raft-mediated endocytosis. Nature 2005; 436: 78-86.
38. Mor A, Philips MR. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 2006; 24: 771-800.
39. Roy S, Wyse B, Hancock JF. H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis. Mol Cell Biol 2002; 22: 5128-5140.
40. Jiang X, Sorkin A. Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells. Mol Biol Cell 2002; 13: 1522-1535.
41. Daniotti M, Oggionni M, Ranzani T, Vallacchi V, Campi V, Di Stasi D, Torre GD, Perrone F, Luoni C, Suardi S, Frattini M, Pilotti S, Anichini A, Tragni G, Parmiani G et al. BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 2004; 23: 5968-5977.
42. Friedl P, Wolf K. Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-374.
43. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003; 5: 711-719.
44. Caswell PT, Spence HJ, Parsons M, White DP, Clark K, Cheng KW, Mills GB, Humphries MJ, Messent AJ, Anderson KI, McCaffrey MW, Ozanne BW, Norman JC. Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev Cell 2007; 13: 496-510.
45. Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N, Liu J, Smith-McCune K, Lu KH, Fishman D, Gray JW, Mills GB. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004; 10: 1251-1256.
46. Colaluca IN, Tosoni D, Nuciforo P, Senic-Matuglia F, Galimberti V, Viale G, Pece S, Di Fiore PP. NUMB controls p53 tumour suppressor activity. Nature 2008; 451: 76-80.
47. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell 2008; 132: 681-696.
48. Brinkley BR. Managing the centrosome numbers game: From chaos to stability in cancer cell division. Trends Cell Biol 2001; 11: 18-21.
49. Montagnac G, Echard A, Chavrier P. Endocytic traffic in animal cell cytokinesis. Curr Opin Cell Biol 2008;
50. Royle SJ, Bright NA, Lagnado L. Clathrin is required for the function of the mitotic spindle. Nature 2005; 434: 1152-1157.
51. Thompson HM, Skop AR, Euteneuer U, Meyer BJ, McNiven MA. The large GTPase dynamin associates with the spindle midzone and is required for cytokinesis. Curr Biol 2002; 12: 2111-2117.
52. Thompson HM, Cao H, Chen J, Euteneuer U, McNiven MA. Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion. Nat Cell Biol 2004; 6: 335-342.
53. Lehtonen S, Shah M, Nielsen R, Iino N, Ryan JJ, Zhou H, Farquhar MG. The endocytic coat protein ARH associates with motor and centrosomal proteins and is involved in centrosome assembly and cytokinesis. Mol Biol Cell 2008; 19: 2949-2961.
54. Miserey-Lenkei S, Couedel-Courteille A, Del Nery E, Bardin S, Piel M, Racine V, Sibarita JB, Perez F, Bornens M, Goud B. A role for the Rab6A'GTPase in the inactivation of the Mad2-spindle checkpoint. EMBO J 2006; 25: 278-289.
55. Boucrot E, Kirchhausen T. Endosomal recycling controls plasma membrane area during mitosis. Proc Natl Acad Sci U S A 2007; 104: 7939-7944.
56. Meyers J, Craig J, Odde DJ. Potential for control of signaling pathways via cell size and shape. Curr Biol 2006; 16: 1685-1693.
57. Bastiaens P, Caudron M, Niethammer P, Karsenti E. Gradients in the self-organization of the mitotic spindle. Trends Cell Biol 2006; 16: 125-134.
58. Floyd S, De Camilli P. Endocytosis proteins and cancer: A potential link? Trends Cell Biol 1998; 8: 299-301.
59. Sargin B, Choudhary C, Crosetto N, Schmidt MH, Grundler R, Rensinghoff M, Thiessen C, Tickenbrock L, Schwable J, Brandts C, August B, Koschmieder S, Bandi SR, Duyster J, Berdel WE et al. Flt3-dependent transformation by inactivating c-Cbl mutations in AML. Blood 2007; 110: 1004-1012.
60. Shtiegman K, Kochupurakkal BS, Zwang Y, Pines G, Starr A, Vexler A, Citri A, Katz M, Lavi S, Ben-Basat Y, Benjamin S, Corso S, Gan J, Yosef RB, Giordano S et al. Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. Oncogene 2007; 26: 6968-6978.
61. Grandal MV, Zandi R, Pedersen MW, Willumsen BM, van Deurs B, Poulsen HS. EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes. Carcinogenesis 2007; 28: 1408-1417.
62. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288: C494-C506.
63. Hayashi K, Matsuda S, Machida K, Yamamoto T, Fukuda Y, Nimura Y, Hayakawa T, Hamaguchi M. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res 2001; 61: 2361-2364.
64. Lee H, Park DS, Razani B, Russell RG, Pestell RG, Lisanti MP. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am J Pathol 2002; 161: 1357-1369.
65. Enari M, Ohmori K, Kitabayashi I, Taya Y. Requirement of clathrin heavy chain for p53-mediated transcription. Genes Dev 2006; 20: 1087-1099.
66. Fish KN, Schmid SL, Damke H. Evidence that dynamin-2 functions as a signal-transducing GTPase. J Cell Biol 2000; 150: 145-154.
67. Pilecka I, Banach-Orlowska M, Miaczynska M. Nuclear functions of endocytic proteins. Eur J Cell Biol 2007; 86: 533-547.
68. Toret CP, Drubin DG. The budding yeast endocytic pathway. J Cell Sci 2006; 119: 4585-4587.
69. Elde NC, Morgan G, Winey M, Sperling L, Turkewitz AP. Elucidation of clathrin-mediated endocytosis in tetrahymena reveals an evolutionarily convergent recruitment of dynamin. PLoS Genet 2005; 1: E52.
70. Okada T, You L, Giancotti FG. Shedding light on Merlin's wizardry. Trends Cell Biol 2007; 17: 222-229.
71. Hsu T, Adereth Y, Kose N, Dammai V. Endocytic function of von Hippel-Lindau tumor suppressor protein regulates surface localization of fibroblast growth factor receptor 1 and cell motility. J Biol Chem 2006; 281: 12069-12080.
72. Citri A, Yarden Y. EGF-ERBB signalling: Towards the systems level. Nat Rev Mol Cell Biol 2006; 7: 505-516.
73. Bradley SV, Smith MR, Hyun TS, Lucas PC, Li L, Antonuk D, Joshi I, Jin F, Ross TS. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies. Cancer Res 2007; 67: 8923-8931.
74. Bradley SV, Holland EC, Liu GY, Thomas D, Hyun TS, Ross TS. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Res 2007; 67: 3609-3615.
75. Rao DS, Hyun TS, Kumar PD, Mizukami IF, Rubin MA, Lucas PC, Sanda MG, Ross TS. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J Clin Invest 2002; 110: 351-360.
76. Rao DS, Bradley SV, Kumar PD, Hyun TS, Saint-Dic D, Oravecz-Wilson K, Kleer CG, Ross TS. Altered receptor trafficking in Huntingtin interacting protein 1-transformed cells. Cancer Cell 2003; 3: 471-482.
77. Yu L, Hui-chen F, Chen Y, Zou R, Yan S, Chun-xiang L, Wu-ru W, Li P. Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential. Clin Exp Metastasis 1999; 17: 213-219.
78. Fukui K, Tamura S, Wada A, Kamada Y, Igura T, Kiso S, Hayashi N. Expression of Rab5a in hepatocellular carcinoma: Possible involvement in epidermal growth factor signaling. Hepatol Res 2007; 37: 957-965.
79. Young TW, Rosen DG, Mei FC, Li N, Liu J, Wang XF, Cheng X. Up-regulation of tumor susceptibility gene 101 conveys poor prognosis through suppression of p21 expression in ovarian cancer. Clin Cancer Res 2007; 13: 3848-3854.
80. Pei L, Peng Y, Yang Y, Ling XB, Van Eyndhoven WG, Nguyen KC, Rubin M, Hoey T, Powers S, Li J. PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. Cancer Res 2002; 62: 5420-5424.
81. Nguyen LN, Holdren MS, Nguyen AP, Furuya MH, Bianchini M, Levy E, Mordoh J, Liu A, Guncay GD, Campbell JS, Parks WT. Sorting nexin 1 down-regulation promotes colon tumorigenesis. Clin Cancer Res 2006; 12: 6952-6959.
82. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318: 1108-1113.